Clinical and morphological features of undifferentiated monomorphous GH/TSH-secreting pituitary adenoma

European Journal of Endocrinology

Volumn 140, Issue 6, 1999, Pages 528-537

  Škorić, Tanja ^a   Koršić, Mirko ^a,b   Žarković, Kamelija ^b   Plavšić, Vesna ^a   Bešenski, Nada ^b   Breskovac, Ljiljana ^a   Giljević, Zlatko ^a   Paladino, Josip ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; GROWTH HORMONE; PROLACTIN; THYROTROPIN;

ACROMEGALY; ADULT; ARTICLE; CASE REPORT; CELL ULTRASTRUCTURE; COMPUTER ASSISTED TOMOGRAPHY; ECTOPIC HORMONE PRODUCTION; ELECTRON MICROSCOPY; GROWTH HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; THYROTROPIN RELEASE;

ADENOMA; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; HUMAN GROWTH HORMONE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM RECURRENCE, LOCAL; OCTREOTIDE; PITUITARY NEOPLASMS; PROLACTIN; THYROTROPIN; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0345551897     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1400528     Document Type: Article

References (27)

1. Smallridge RC. Thyrotrophinomas. In Clinical Endocrine Oncology, pp 221-224. Eds R Sheaves, PJ Jenkins & JH Wass. Oxford: Blackwell Science Ltd, 1997.
2. Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC & Weintraub BD. Thyrotropin-secreting pituitary tumors. Endocrine Reviews 1996 17 610-638.
3. McDermott MT & Ridgway EC. Central hyperthyroidism. Endocrinology and Metabolism Clinics of North America 1998 27 187-203.
4. Trouillas J, Girod C, Loras B, Claustrat B, Sassolas G, Perrin G et al. The TSH secretion in the human pituitary adenomas. Pathology Research and Practice 1988 183 569-600.
5. Felix I, Asa SL, Kovacs K, Horvath E & Smyth HS. Recurrent plurihormonal bimorphous pituitary adenoma producing growth hormone, thyrotropin, and prolactin. Archives of Pathology and Laboratory Medicine 1994 118 66-70.
6. Malarkey WB, Kovacs K & O'Dorisio TM. Response of GH- and TSH-secreting pituitary adenoma to a somatostatin analogue (SMS 201-995): evidence that GH and TSH coexist in the same cell and secretory granules. Neuroendocrinology 1989 49 267-274.
7. Kuzuya N, Inoue K, Ishibashi M, Murayama Y, Koide Y, Ito K et al. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, α-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells. Journal of Clinical Endocrinology and Metabolism 1990 71 1103-1111.
8. Fazekas I, Pasztor E, Slowik F, Balint K, Dobronyi I, Bacsy E et al. Pathological and experimental investigations in a case of gigantism. Acta Neuropathologica 1993 85 167-174.
9. Clore JN, Sharpe AR, Singh Sahni K, Kovacs K & Blackard WG. Thyrotropin-induced hyperthyroidism: evidence for common progenitor stem cell. American Journal of the Medical Sciences 1988 295 3-5.
10. Beck-Peccoz P, Piscitelli G, Amr S, Ballabio M, Bassetti M, Giannattasio G et al. Endocrine, biochemical and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH), and α-subunit: evidence for secretion of TSH with increased bioactivity. Journal of Clinical Endocrinology and Metabolism 1986 62 704-711.
11. Shi SR, Imam SA, Young L, Cote RJ & Taylor RJ. Antigen retrieval immunohistochemistry under the influence of pH using monoclonal antibodies. Journal of Histochemistry and Cytochemistry 1995 43 193-201.
12. Plavšić V, Koršić M, Žarković N, Rogić D, Žarković K, Giljević Z et al. Glycoprotein hormone alpha-subunit release in sera and tumor cell cultures and the responses to thyrotropin-releasing hormone in the patients with clinically nonfunctioning pituitary adenomas. Clinical Laboratory 1996 42 285-289.
13. Sheaves R & Wass JAH. Acromegaly. In Clinical Endocrine Oncology, pp 195-203. Eds R Sheaves, PJ Jenkins & JH Wass. Oxford: Blackwell Science Ltd, 1997.
14. Barkan AL, Kelch RP, Hopwood NJ & Beitins IZ. Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995. Journal of Clinical Endocrinology and Metabolism 1988 66 16-23.
15. Yang I, Park S, Woo J, Kim S, Kim J, Kim Y et al. Growth hormone response to the hypothalamic somatostatinergic activity in acromegalic patients. Journal of Clinical Endocrinology and Metabolism 1997 82 2492-2496.
16. Koide Y, Kugai N, Kimura S, Fujita T, Kameya T, Azukizawa M et al. A case of pituitary adenoma with possible simultaneous secretion of thyrotropin and follicle stimulating hormone. Journal of Clinical Endocrinology and Metabolism 1982 54 397-403.
17. Savastano S, Lombardi G, Merola B, Milleto P. DiPrisco B, Manco A et al. Hyperthyroidism due to a thyroid-stimulating hormone (TSH)-secreting pituitary adenoma associated with functional hyperprolactinaemia. Acta Endocrinologica 1987 116 452-458.
18. Horvath E, Kovacs K, Singer W, Smyth HS, Killinger DW, Erzin C et al. Acidophil stem cell adenoma of the human pituitary: clinicopathologic analysis of 15 cases. Cancer 1981 47 761-771.
19. Aylwin SJB, King A, Blenke A, Geddes JF, Wood FD, Monson JP et al. Free alpha-subunit and intact TSH secretion in vitro are closely associated in human somatotroph adenomas. European Journal of Endocrinology 1998 139 378-386.
20. Marks WA, Brumback RA, Schaefer GB, Pendleton BD, Farris BK & Culbertson JL. Acidophil stem-cell pituitary adenoma in a prepubescent female. Journal of Neurosurgery 1989 70 266-270.
21. Page MD, Bridges LR, Barth JH, McNichol AM & Belchetz PE. Development of acromegaly during treatment of hyperprolactinemia with bromocriptine: an unusual acidophil stem cell adenoma. Journal of Clinical Endocrinology and Metabolism 1996 81 4484-4487.
22. Chanson PH, Weintraub BD & Harris AG. Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. Annals of Internal Medicine 1993 119 236-240.
23. Beck-Peccoz P, Mariotti S, Guillausseau PJ, Medri G, Piscitelli G, Bertoli A et al. Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analogue SMS 201-995. Journal of Clinical Endocrinology and Metabolism 1989 68 208-214.
24. Wemeau JL, Dewailly D, Leroy R, D'Herbomez M, Mazzuca M, Decoulx et al. Long term treatment with the somatostatin analogue SMS 201-995 in a patient with a thyrotropin- and growth hormone-secreting pituitary adenoma. Journal of Clinical Endocrinology and Metabolism 1988 66 636-639.
25. Takano K, Ajima M, Teramoto A, Hata K & Yamashita N, Mechanisms of action of somatostatin on human TSH-secreting adenoma cells. American Journal of Physiology 1995 268 E558-E564.
26. Patel YC, Greenwood M, Panetta R, Hukovic N, Grigorakis S, Robertson L et al. Molecular biology of somatostatin receptor subtypes. Metabolism 1996 45 31-38.
27. Stevenaert A & Beckers A. Presurgical octreotide: treatment in acromegaly. Metabolism 1996 45 72-74.